278 related articles for article (PubMed ID: 25415617)
1. Insulin signaling: implications for podocyte biology in diabetic kidney disease.
Coward R; Fornoni A
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):104-10. PubMed ID: 25415617
[TBL] [Abstract][Full Text] [Related]
2. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.
Brosius FC; Coward RJ
Adv Chronic Kidney Dis; 2014 May; 21(3):304-10. PubMed ID: 24780459
[TBL] [Abstract][Full Text] [Related]
3. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
4. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
6. Lipid mediators of insulin signaling in diabetic kidney disease.
Mitrofanova A; Sosa MA; Fornoni A
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1241-F1252. PubMed ID: 31545927
[TBL] [Abstract][Full Text] [Related]
7. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
8. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway.
Xu J; Deng Y; Wang Y; Sun X; Chen S; Fu G
Cell Prolif; 2020 Feb; 53(2):e12738. PubMed ID: 31957155
[TBL] [Abstract][Full Text] [Related]
9. Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy.
Liu N; Xu L; Shi Y; Zhuang S
J Diabetes Res; 2017; 2017():3560238. PubMed ID: 28512641
[TBL] [Abstract][Full Text] [Related]
10. P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy.
Qian C; Lu J; Che X; Min L; Wang M; Song A; Lu R; Gu L; Xie K
Free Radic Biol Med; 2023 Aug; 204():337-346. PubMed ID: 37245531
[TBL] [Abstract][Full Text] [Related]
11. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
12. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
13. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
Jin J; Gong J; Zhao L; Li Y; He Q
Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
[TBL] [Abstract][Full Text] [Related]
14. The insulin receptor and the kidney.
Hale LJ; Coward RJ
Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):100-6. PubMed ID: 23104093
[TBL] [Abstract][Full Text] [Related]
15. Nutrient sensing, signaling transduction, and autophagy in podocyte injury: implications for kidney disease.
Zha D; Wu X
J Nephrol; 2023 Jan; 36(1):17-29. PubMed ID: 35704261
[TBL] [Abstract][Full Text] [Related]
16. Podocytes as a target of insulin.
Coward RJ; Saleem MA
Curr Diabetes Rev; 2011 Jan; 7(1):22-7. PubMed ID: 21067503
[TBL] [Abstract][Full Text] [Related]
17. Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes.
Lai W; Luo D; Li Y; Li Y; Wang Q; Hu Z; Ye Z; Peng H
FASEB J; 2023 Oct; 37(10):e23175. PubMed ID: 37742293
[TBL] [Abstract][Full Text] [Related]
18. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway.
Zhan X; Yan C; Chen Y; Wei X; Xiao J; Deng L; Yang Y; Qiu P; Chen Q
Mol Immunol; 2018 Dec; 104():61-68. PubMed ID: 30439604
[TBL] [Abstract][Full Text] [Related]
19. Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.
Jauregui A; Mintz DH; Mundel P; Fornoni A
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):539-45. PubMed ID: 19724224
[TBL] [Abstract][Full Text] [Related]
20. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
